Article
TGFβ signaling limits lineage plasticity in prostate cancer.
PLoS genetics - 1 May 2018
Hao Yi, Bjerke Glen A, Pietrzak Karolina, Melhuish Tiffany A, Han Yu, Turner Stephen D, Frierson Henry F, Wotton David
Abstract excerpt
Although treatment options for localized prostate cancer (CaP) are initially effective, the five-year survival for metastatic CaP is below 30%. Mutation or deletion of the PTEN tumor suppressor is a frequent event in metastatic CaP, and inactivation of the transforming growth factor (TGF) ß signaling pathway is associated with more advanced disease. We previously demonstrated that mouse models of CaP based on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
